Estradiol Patch vs Pill
Transdermal estradiol delivers the same molecule but bypasses first-pass hepatic metabolism. That single difference reshapes the clotting, inflammation, triglyceride, and SHBG profile. For most BHRT candidates, transdermal is the modern provider-preferred default; oral retains specific use cases.
Transdermal is the provider-preferred default for most BHRT candidates — particularly when cardiovascular risk, clotting history, triglyceride pattern, or free-testosterone preservation are part of the picture.
Explore pathwayOral estradiol retains specific use cases reviewed individually — never selected by patient preference alone.
Explore pathwayEducational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.
Frequently asked
Is the patch as effective as the pill?
Yes. The molecule is identical; serum estradiol levels achieved with appropriately dosed transdermal delivery are clinically equivalent for symptom control.
Why does oral estradiol raise SHBG?
First-pass hepatic exposure stimulates SHBG production. Transdermal delivery, by bypassing the liver, does not.
Take the optimization assessment.
The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.
Begin assessment